FDA panel endorses new ketamine nasal spray for severe depression
Atlanta Journal-Constitution: Lee Hoffer, associate professor of anthropology and professor of psychiatry, served as a temporary voting member on an FDA panel that recently endorsed a ketamine-based depression medication. He explained why the FDA will need to keep a close watch on the medication.